Protein Polymer Technologies, Inc.

Biotechnology device company announces intention to acquire Surgica Corporation

Published in Medical Patent Law Weekly, August 10th, 2005

Protein Polymer Technologies, Inc., (PPTI) announced that it has issued a letter of intent to acquire Surgica Corporation.

Embolization is a minimally invasive procedure performed by interventional radiologists, used to treat uterine fibroids, liver cancer and neurovascular conditions.

Under the terms of the arrangement, PPTI would acquire Surgica's assets with a combination of PPTI common stock and cash. Assets comprise intellectual property including one issued patent, product lines and a U.S. Food and Drug Administration (FDA)-approved manufacturing facility. The company currently has three FDA- approved polyvinyl alcohol (PVA) product lines - PVA...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Source: Medical Patent Law Weekly (2005-08-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry